Emerging personalized treatment approaches for chronic urticari.
Stanford Study of Paxlovid for Long COVID Stopped Early
Enrollment into a small trial of nirmatrelvir/ritonavir (Paxlovid) for long COVID — one that previously garnered attention for investigators not wearing masks — has been